A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity

Journal of Virological Methods

Volumn 75, Issue 1, 1998, Pages 9-20

  Malmsten, Anders ^a   Ekstrand, D Henric L ^a,e   Åkerblom, Lennart ^b   Gronowitz, J Simon ^c   Källander, Clas F R ^c   Bendinelli, Mauro ^d   Matteucci, Donatella ^d  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c Cavidi AB   (Sweden)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Ecotropic recombinant virus; Feline leukemia virus; Moloney murine leukemia virus; Retrovirus; Reverse transcriptase (RT); RT activity blocking antibody

Indexed keywords

BLOCKING ANTIBODY; MAGNESIUM; RNA DIRECTED DNA POLYMERASE;

ANIMAL CELL; ANTIGENICITY; ARTICLE; COLORIMETRY; CROSS REACTION; ENZYME ACTIVITY; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; LENTIVIRINAE; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VISNA VIRUS;

3T3 CELLS; ANIMALS; CATS; CELL LINE; CERCOPITHECUS AETHIOPS; COLORIMETRY; CRICETINAE; HUMANS; ISOENZYMES; LENTIVIRUS; MICE; MOLONEY MURINE LEUKEMIA VIRUS; RNA-DIRECTED DNA POLYMERASE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; VERO CELLS;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; LENTIVIRUS; MAMMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS; VISNA VIRUS;

EID: 0031761715     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00091-3     Document Type: Article

References (41)

1. Advani, M., Imagawa, D.T., Lee, M.H., Sano, K., Morales, F., Mitsuyasu, R.T., Detels, R., 1989. Cross-sectional study of reverse transcriptase-inhibiting antibody as a marker of acquired immune deficiency syndrome. J. Clin. Microbiol. 27, 1453-1455.
2. Akerblom, L., Strömstedt, K., Höglund, S., Osterhaus, A., Morein, B., 1989. Formation and characterization of FeLV ISCOMs. Vaccine 7, 142-146.
3. Awad, R.J.K., Corrigan, G.E., Ekstrand, D.H.L., Thorstensson, R., Källander, C.F.R., Gronowitz, J.S., 1997. Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay. J. Clin. Microbiol. 35, 1080-1089.
4. Baltimore, D., 1970. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226, 1209-1211.
5. Barsov, E.V., Hughes, S.H., 1996. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus. J. Virol. 70, 3922-3929.
6. Burns, J.C., Friedmann, T., Driever, W., Burrascano, M., Yee, J.K., 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [see comments]. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
7. Deo, Y., Ghebremariam, H., Cloyd, M., 1994. Detection and characterization of murine ecotropic recombinant virus in myeloma and hybridoma cells. Hybridoma 13, 69-76.
8. Eberle, J., Seibl, R., 1992. A new method for measuring reverse transcriptase activity by ELISA. J. Virol. Methods 40, 347-356.
9. Ekstrand, D.H.L., Böttiger, D., Andersson, H., Gronowitz, J.S., Källander, C.F.R., 1997. Reverse transcriptase activity and corresponding activity blocking antibody for monitoring SIVsm infection in macaques. AIDS Res. Hum. Retrovir. 13, 601-610.
10. Ekstrand, D.H.L., Awad, R.J.K., Källander, C.F.R., Gronowitz, J.S., 1996. A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive-product detection, with special reference to human-immunodeficiency-virus isolation. Biotechnol. Appl. Biochem. 23, 95-105.
11. Fujiwara, T., Grimm, E.A., Roth, J.A., 1994. Gene therapeutics and gene therapy for cancer. Curr. Opin. Oncol. 6, 96-105.
12. Heidecker, G., Messing, J., 1987. A method for cloning full-length cDNA in plasmid vectors. Methods Enzymol. 154, 28-41.
13. Hughes, G.A., Barnett, Y.A., Allen, J.M., 1995. Detection of reverse transcriptase in culture medium for mammary tumour cell lines: a comparison of an established radio-labelling technique and a contemporary non-isotopic technique. Br. J. Biomed. Sci. 52, 2-8.
14. Kornfeld, H., Riedel, N., Viglianti, G.A., Hirsch, V., Mullins, J.I., 1987. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature 326, 610-613.
15. Kozak, C.A., Ruscetti, S., 1992. Retroviruses in rodents. In: Levy, J.A. (Ed.), The Retroviridae, vol. 1. Plenum Press, New York, pp. 405-481.
16. Laurence, J., Saunders, A., Kulkosky, J., 1987. Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity. Science 235, 1501-1504.
17. Levy, J.A. (Ed.), 1992. The Retroviridae, vol. 1-3. Plenum Press, New York.
18. Matteucci, D., Baldinotti, F., Mazzetti, P., et al., 1993. Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction. J. Clin. Microbiol. 31, 494-501.
19. Matteucci, D., Mazzetti, P., Baldinotti, F., Zaccaro, L., Bendinelli, M., 1995. The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation. Vet. Immunol. Immunopathol. 46, 71-82.
20. Miller, A.D., 1990. Retrovirus packaging cells. Hum. Gene Ther. 1, 5-14.
21. Moloney, J.B., 1960. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J. Natl. Cancer Inst. Monogr. 24, 933.
22. Morgenstern, J.P., Land, H., 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
23. Mulligan, R.C., 1993. The basic science of gene therapy. Science 260, 926-932.
24. Neumüller, M., Karlsson, A., Lennerstrand, J., et al., 1991. HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables. J. Med. Virol. 34, 55-63.
25. Okayama, H., Kawaichi, M., Brownstein, M., Lee, F., Yokota, T., Arai, K., 1987. High-efficiency cloning of full-length cDNA; construction and screening of cDNA expression libraries for mammalian cells. Methods Enzymol. 154, 3-28.
26. Patience, C., Takeuchi, Y., Weiss, R.A., 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3, 282-286.
27. Porstmann, T., Meissner, K., Glaser, R., Dopel, S.H., Sydow, G., 1991. A sensitive non-isotopic assay specific for HIV-1 associated reverse transcriptase. J. Virol. Methods 31, 181-188.
28. Roth, M.J., Tanese, N., Goff, S.P., 1985. Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J. Biol. Chem. 260, 9326-9335.
29. Schnierle, B.S., Stitz, J., Bosch, V., et al., 1997. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA 94, 8640-8645.
30. Sjölander, S., Hansen, J.E., Lövgren Bengtsson, K., Akerblom, L., Morein, B., 1996. Induction of homologous virus neutralizing antibodies in guinea pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems. Vaccine 14, 344-352.
31. Snowden, W., Coughlan, N., Tisdale, M., Stammers, D.K., 1993. Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1. J. Acquired Immune Defic. Syndr. 6, 1187-1193.
32. Spector, D.H., Wade, E., Wright, D.A., Koval, V., Clark, C., Jaquish, D., Spector, S.A., 1990. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64, 2298-2308.
33. Suzuki, K., Saito, T., Kondo, M., et al., 1995. Poly A-linked non-isotopic microtiter plate reverse transcriptase assay for sensitive detection of clinical human immunodeficiency virus isolates. J. Virol. Methods 55, 347-356.
34. Temin, HM., Mizutani, S., 1970. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226, 1211-1213.
35. Todaro, G.J., Benveniste, R.E., Lieber, M.M., Sherr, C.J., 1974. Characterisation of a Type C virus released from the porcine cell line PK (15). Virology 58, 65-74.
36. Tolari, F., Guarda, F., Rosati, S., Valenza, F., 1991. Proc. Ann. Meet. Ital. Soc. Vet. Sci. 45, 1083-1087.
37. Urabe, T., Sano, K., Nakano, T., et al., 1994. Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay. J. Clin. Microbiol. 32, 1870-1875.
38. Urabe, T., Sano, K., Tanno, M., et al., 1992. A non-radioisotopic reverse transcriptase assay using biotin-11-deoxyuridinetriphosphate on primer-immobilized microtiter plates. J. Virol. Methods 40, 145-154.
39. Weber, J., Grosse, F., 1989. Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA. Nucleic Acids Res. 17, 1379-1393.
40. Wolfs, T.F., Geelen, J.L., Schellekens, H., Barin, F., Dekker, J.T., Goudsmit, J., 1989. Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection. AIDS Res. Hum. Retrovir. 5, 535-540.
41. Xiong, Y., Eickbush, T.H., 1990. Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9, 3353-3362.